Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.73 |
| ▸ | HPGD | P15428 | 3/20 | 0.73 |
| ▸ | RAB9A | P51151 | 3/20 | 0.73 |
| ▸ | HTT | P42858 | 2/20 | 0.73 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.73 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.55 |
| ▸ | WNT3A | P56704 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | SCD | O00767 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.44 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzimidazole SCHEMBL16516335 | 0.89 | SMN1; SMN2 (0.57) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL8901469 | 0.89 | SMN1; SMN2 (0.57) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL4774682 | 0.87 | KDM4E (0.56) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzamide SCHEMBL3698973 | 0.86 | RAB9A (0.56) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL4631509 | 0.85 | SMN1; SMN2 (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL1883999 | 0.85 | SMN1; SMN2 (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL16516333 | 0.85 | KDM4E (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL29286632 | 0.85 | RAB9A (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL158526 | 0.85 | SMN1; SMN2 (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 | |
| Benzimidazole SCHEMBL28469449 | 0.85 | KDM4E (0.54) | ALDH1A1HPGDRAB9AHTTSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992545-B2 | Aqueous cosmetic compositions containing pelargonic acid esters | NOVAMONT S.P.A. (IT) | 2024-05-28 | — | — | US | disclosed |
| US-11584772-B2 | N4-modified cytidine nucleotides and their use | VILNIUS UNIVERSITY (LT) | 2023-02-21 | — | — | US | disclosed |
| US-20200270295-A1 | N4-MODIFIED CYTIDINE NUCLEOTIDES AND THEIR USE | VILNIUS UNIVERSITY (LT) | 2020-08-27 | — | — | US | disclosed |
| EP-3681897-A1 | N4-MODIFIED CYTIDINE NUCLEOTIDES AND THEIR USE | Vilnius University (LT) | 2020-07-22 | — | — | EP | disclosed |
| CN-110161742-A | Black matrix\" and preparation method thereof, display panel | 深圳市华星光电技术有限公司 | 2019-08-23 | — | — | CN | disclosed |
| WO-2019053609-A1 | N4-MODIFIED CYTIDINE NUCLEOTIDES AND THEIR USE | VILNIUS UNIVERSITY (LT) | 2019-03-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11584772-B2 | N4-modified cytidine nucleotides and their use | PNP, RNGTT, ADA | ALDH1A1 808/4885HPGD 1757/4885RAB9A 2956/4885 |
| US-20200270295-A1 | N4-MODIFIED CYTIDINE NUCLEOTIDES AND THEIR USE | PNP, RNGTT, ADA | ALDH1A1 808/4885HPGD 1757/4885RAB9A 2956/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.